University of Utah

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Utah sits in the top decile of US sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count).

818 total trials 138 currently recruiting 492 completed early-phase tilt top decile by trial count

University of Utah: 818 sponsored US clinical trials, 138 recruiting.

University of Utah sponsors 818 registered US clinical trials on ClinicalTrials.gov, 138 of them currently recruiting, and 492 completed. 45 of these trials are in Phase 3-4 (later-stage) and 268 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Low Back Pain, with 8 trials.

Top-decile sponsor footprint

University of Utah ranks in the top decile of sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 41/100

492 of 611 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

818 total, page 3 of 17

RECRUITING Early Phase 1

Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System

NCT05291507

RECRUITING Phase 2

Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC

NCT05464082

RECRUITING NA

Neural Mechanisms of Meditation for Opioid-Treated Chronic Low Back Pain

NCT05607381

RECRUITING Phase 4

Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start

NCT05444582

RECRUITING Phase 2

A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)

NCT05201144

RECRUITING NA

Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial

NCT05471908

RECRUITING Phase 4

Conventional vs Bipolar SIJ RFA for Treatment of Sacroiliac Joint Pain

NCT05409443

RECRUITING Phase 2

RiLuzole to Reduce Atrial FIb Study Using Holter Monitoring

NCT05292209

RECRUITING NA

Conservative Management for PAS Pilot

NCT05139498

RECRUITING NA

Immune Cells During Disuse and Recovery

NCT04416191

RECRUITING NA

SMART Embedded Intervention for Military Postsurgical Engagement Readiness

NCT05050409

RECRUITING Phase 2

The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis

NCT04372615

RECRUITING Phase 2

Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial

NCT05168618

RECRUITING Phase 2

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

NCT04844528

RECRUITING Early Phase 1

PRevention Of Methamphetamine Use Among Postpartum Women Trial (PROMPT)

NCT05128071

RECRUITING Phase 2

Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial

NCT05183854

RECRUITING Phase 2

Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior

NCT05767385

RECRUITING Phase 3

Nonpharmacologic Pain Management in FQHC Primary Care Clinics

NCT04923334

RECRUITING Phase 1

Hypoxia Imaging for Esophageal Cancer to Guide Personalized Radiation Therapy

NCT04846309

RECRUITING Phase 1

Ketamine Assisted Psychotherapy for Opioid Use Disorder

NCT04892251

RECRUITING Phase 1

Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics

NCT04315233

RECRUITING NA

Cycle and Stroke With Biofeedback for Power Symmetry

NCT06857916

RECRUITING NA

High Frequency Oscillatory Ventilation Versus High Frequency Jet Ventilation for Congenital Diaphragmatic Hernia

NCT04774848

RECRUITING NA

Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Feedback?

NCT05505513

RECRUITING Phase 3

HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants

NCT04177914

RECRUITING NA

Treatment for Sacroiliac Joint Pain Using Platelet-rich Plasma (PRP) Versus Steroid/Anesthetic

NCT05121961

RECRUITING NA

Biomarkers of Increased Free Living Sleep Time

NCT04214184

RECRUITING NA

Effects of Fixation Technique On Thoracic Epidural Catheter Displacement

NCT03976154

RECRUITING Phase 3

Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer

NCT03422198

RECRUITING Early Phase 1

New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)

NCT04600115

RECRUITING NA

Improving Myoelectric Prosthetic and Orthotic Limb Control

NCT05509101

RECRUITING Phase 1

Stereotactic Radiosurgery Dose Escalation for Brain Metastases

NCT02390518

RECRUITING

Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease

NCT01099982

RECRUITING

HCRN Core Data Project: Characterizing Patient Populations in the Hydrocephalus Clinical Research Network (HCRN)

NCT00670735

RECRUITING

ColoCare Study - Colorectal Cancer Cohort

NCT02328677

RECRUITING

Natural History, Diagnosis, and Outcomes for Leukodystrophies

NCT03639285

RECRUITING

Molecular Biology of Polycythemia and Thrombocytosis

NCT00722527

RECRUITING

NETs: Protection or Harm in Neonatal Inflammation or Infection

NCT00747851

ACTIVE NOT RECRUITING NA

Scaling up Building Healthy Families

NCT07404839

ACTIVE NOT RECRUITING NA

PREVENT HPV -Related Cancers Trial

NCT07217145

ACTIVE NOT RECRUITING NA

UG3 Pilot Clinical Trial

NCT07073898

ACTIVE NOT RECRUITING NA

PASO A PASO: Tailored Diabetes Prevention Program for Spanish-Speaking Communities Feasibility Study

NCT07392008

ACTIVE NOT RECRUITING NA

Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool

NCT05706311

ACTIVE NOT RECRUITING NA

A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication.

NCT06423365

ACTIVE NOT RECRUITING NA

Massage: Neuroimaging and Correlates of Response - 6-week Study

NCT07190326

ACTIVE NOT RECRUITING NA

Do Wound Protectors Reduce Contamination in Total Shoulder Arthroplasty?

NCT06513182

ACTIVE NOT RECRUITING NA

Massage: Neuroimaging and Correlates of Response - 1-week Study

NCT07190313

ACTIVE NOT RECRUITING

Anterior Segment Optical Coherence Tomography Microstent Positioning

NCT06666751

ACTIVE NOT RECRUITING NA

The MyLungHealth Study Protocol: Engaging Patients to Enable Interoperable Lung Cancer Decision Support at Scale

NCT06338592

ACTIVE NOT RECRUITING

Physiologic Burden to the Surgeon During Orthopaedic Surgery

NCT06180044

← Previous Page 3 of 17 Next →

Phase Distribution

PhaseTrial count
Phase 1 145
Phase 2 123
Phase 3 18
Phase 4 27

What is open in the University of Utah pipeline

138 recruiting of 818 indexed (17% open); 492 completed (60%).

Phase mix: 45 late (III/IV) vs 268 early (I/II) (early-phase heavy).

Top condition: Low Back Pain (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Utah: open-pipeline peers nationwide

Peers matched on 818 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 14%16%18%20%22% Total trials Recruiting share University of UtahUniversity of Texas Southwestern Medical CenterUniversity of ChicagoDana-Farber Cancer InstituteUniversity of California, San DiegoUniversity of HawaiiPenn State UniversityAdventHealthCSL Behring
University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 818 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

What to do with this University of Utah page

818 registered trials is a research-attention snapshot, not an endorsement of University of Utah or any single study.

  • 138 of University of Utah's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Low Back Pain is the condition University of Utah studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Low Back Pain trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Utah pipeline card: 818 registered trials from official public datasets.Report a data error.